Franck LESCURE
Partner and Member of the Executive Board
Franck joined Auriga Partners in 2004 and is now responsible for investments in life sciences. He more recently raised AURIGA IV Bioseeds, a seed fund he is heading. Franck currently serves on the board of directors of several portfolio companies including Amoeba, Cytoo, Erytech, Fab'Entech, Median, Pylote and TxCell.
Prior to joining Auriga Partners, Franck was part of the Crédit Lyonnais Private Equity since 2003, after 5 years spent at the Commercial and Medical Departments of Air Liquide Santé, the Healthcare subsidiary of Air Liquide. He began his career in Genset, from 1990 to 1995, in Paris and San Diego, working on therapeutic applications of oligonucleotides and the development of a new-generation DNA synthesizer.
Franck is an alumnus of the Ecole Normale Supérieure and holdss a PhD in Molecular Virology. He is also a graduate of the Institut Pasteur and holds a MBA from Collège des Ingénieurs.
Franck joined Auriga Partners in 2004 and is now responsible for investments in life sciences. He more recently raised AURIGA IV Bioseeds, a seed fund he is heading. Franck currently serves on the board of directors of several portfolio companies including Amoeba, Cytoo, Erytech, Fab'Entech, Median, Pylote and TxCell.
Prior to joining Auriga Partners, Franck was part of the Crédit Lyonnais Private Equity since 2003, after 5 years spent at the Commercial and Medical Departments of Air Liquide Santé, the Healthcare subsidiary of Air Liquide. He began his career in Genset, from 1990 to 1995, in Paris and San Diego, working on therapeutic applications of oligonucleotides and the development of a new-generation DNA synthesizer.
Franck is an alumnus of the Ecole Normale Supérieure and holdss a PhD in Molecular Virology. He is also a graduate of the Institut Pasteur and holds a MBA from Collège des Ingénieurs.